Skip to main content
Erschienen in: Urolithiasis 4/2017

29.08.2016 | Original Paper

Renal stone clinic survey: calcium stone formers’ self-declared understanding of and adherence to physician’s recommendations

verfasst von: Bernhard Hess

Erschienen in: Urolithiasis | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Abstract

Nothing is known about how well stone formers understand physician’s explanations of stone formation, and a few data are available on adherence to provided recommendations. In this study, two groups of recurrent calcium stone formers (RCSFs) were compared. Group 1: 153 consecutive RCSF (118 men, 35 women) referred 1/2011–6/2014. At least 3 months after a 60-75 min consultation explaining metabolic evaluation and therapeutic measures, RCSF received a questionnaire by mail, regarding understanding of stone formation and adherence to therapeutic recommendations (diet, lifestyle, drug treatment). Response rate was 62 %. Group 2 (control): 81 consecutive RCSFs referred 7/2014–3/2016 (60 men, 21 women) were asked to answer the same questionnaire in the stone center while waiting for their follow-up consultation 3 months after starting prevention; response rate was 100 %. Alkali citrate was prescribed in 45 %. Answer sheets were analyzed anonymously, and frequencies of answers were compared by Chi-square test. Results: 67 % (group 1) and 62 % (group 2) indicated >80 % understanding of the given information (NS). Over 80 % adherence to recommendations occurred in 26 and 30 % (NS). Most frequent changes in dietary/lifestyle habits were increases in calcium (93 vs. 89 %) and fluid intakes (81 vs. 78 %); lowering psychosocial stress (23 vs. 24 %) was least popular. Adherence to 100 % on 6–7 days/week was significantly more frequent for medication than for dietary/lifestyle interventions, both in group 1 (84 vs. 24 %, p < 0.001) and group 2 (91 vs. 28 %, p < 0.001). Conclusions: (1) results do not differ whether RCSFs are voluntarily participating by mail or asked to answer questionnaires in the stone clinic; (2) pathophysiologic explanations of stone disease are understood to >80 % by 2/3 of RCSFs; (3) after 3 months, perfect adherence to recommended treatment is more frequent on alkali citrate than on dietary/lifestyle measures; and (4) increasing calcium and fluid intake are the most popular dietary measures.
Literatur
1.
Zurück zum Zitat Tiselius H-G (2016) Metabolic risk-evaluation and prevention of recurrence in stone disease: does it make sense? Urolithiasis 44:91–100CrossRefPubMed Tiselius H-G (2016) Metabolic risk-evaluation and prevention of recurrence in stone disease: does it make sense? Urolithiasis 44:91–100CrossRefPubMed
2.
Zurück zum Zitat Bensalah K, Tuncel A, Raman JD, Bagrodia A, Pearle M, Lotan Y (2009) How physician and patient perceptions differ regarding medical management of stone disease. J Urol 182:998–1004CrossRefPubMed Bensalah K, Tuncel A, Raman JD, Bagrodia A, Pearle M, Lotan Y (2009) How physician and patient perceptions differ regarding medical management of stone disease. J Urol 182:998–1004CrossRefPubMed
3.
Zurück zum Zitat Parks JH, Asplin JR, Coe FL (2001) Patient adherence to long-term medical treatment of kidney stones. J Urol 166:2057–2060CrossRefPubMed Parks JH, Asplin JR, Coe FL (2001) Patient adherence to long-term medical treatment of kidney stones. J Urol 166:2057–2060CrossRefPubMed
4.
Zurück zum Zitat Dauw C, Yi Y, Bierlein MJ, Yan Ph, Alruwally AF, Ghani KR, Wolf JS, Hollenbeck BK, Hollingsworth JM (2015) Medication nonadherence and effectiveness of preventive pharmacological therapy of kidney stones. J Urol 195:648–652CrossRefPubMed Dauw C, Yi Y, Bierlein MJ, Yan Ph, Alruwally AF, Ghani KR, Wolf JS, Hollenbeck BK, Hollingsworth JM (2015) Medication nonadherence and effectiveness of preventive pharmacological therapy of kidney stones. J Urol 195:648–652CrossRefPubMed
5.
Zurück zum Zitat Pietrow PK, Auge BK, Weizer AZ, Delvecchio FC, Silverstein AD, Mathias B, Albala DM, Preminger GM (2003) Durability of the medical management of cystinuria. J Urol 169:68–70CrossRefPubMed Pietrow PK, Auge BK, Weizer AZ, Delvecchio FC, Silverstein AD, Mathias B, Albala DM, Preminger GM (2003) Durability of the medical management of cystinuria. J Urol 169:68–70CrossRefPubMed
6.
Zurück zum Zitat Hess B, Michel R, Takkinen R, Ackermann D, Jaeger Ph (1994) Risk factors for low urinary citrate in calcium nephrolithiasis: low vegetable fibre intake and low urine volume to added to the list. Nephrol Dial Transplant 9:642–649CrossRefPubMed Hess B, Michel R, Takkinen R, Ackermann D, Jaeger Ph (1994) Risk factors for low urinary citrate in calcium nephrolithiasis: low vegetable fibre intake and low urine volume to added to the list. Nephrol Dial Transplant 9:642–649CrossRefPubMed
7.
Zurück zum Zitat Hess B, Mauron H, Ackermann D, Jaeger Ph (1999) Effects of a ‘common sense diet’ on urinary composition and supersaturation in patients with idiopathic calcium urolithiasis. Eur Urol 36:136–143CrossRefPubMed Hess B, Mauron H, Ackermann D, Jaeger Ph (1999) Effects of a ‘common sense diet’ on urinary composition and supersaturation in patients with idiopathic calcium urolithiasis. Eur Urol 36:136–143CrossRefPubMed
8.
Zurück zum Zitat Najem GR, Seebode JJ, Samady AJ, Feuerman M, Friedman L (1997) Stressful life events and risk of symptomatic kidney stones. Int J Epidemiol 26:1017–1023CrossRefPubMed Najem GR, Seebode JJ, Samady AJ, Feuerman M, Friedman L (1997) Stressful life events and risk of symptomatic kidney stones. Int J Epidemiol 26:1017–1023CrossRefPubMed
9.
Zurück zum Zitat Miyaoka R, Ortiz-Alvarado O, Kriedberg C, Alanee S, Chotikawanich E, Monga M (2012) Correlation between stress and kidney stone disease. J Endourol 26:551–555CrossRefPubMed Miyaoka R, Ortiz-Alvarado O, Kriedberg C, Alanee S, Chotikawanich E, Monga M (2012) Correlation between stress and kidney stone disease. J Endourol 26:551–555CrossRefPubMed
10.
Zurück zum Zitat Borghi L, Meschi T, Amato F, Briganti A, Novarini A, Giannini A (1996) Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J Urol 155:839–843CrossRefPubMed Borghi L, Meschi T, Amato F, Briganti A, Novarini A, Giannini A (1996) Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J Urol 155:839–843CrossRefPubMed
11.
Zurück zum Zitat Robertson WG, Peacock M (1980) The cause of idiopathic calcium stone disease: hypercalciuria or hyperoxaluria? Nephron 26:105–110CrossRefPubMed Robertson WG, Peacock M (1980) The cause of idiopathic calcium stone disease: hypercalciuria or hyperoxaluria? Nephron 26:105–110CrossRefPubMed
12.
Zurück zum Zitat Robertson WG, Scurr DS, Bridge CM (1981) Factors influencing crystallization of calcium oxalate in urine—critique. J Cryst Growth 53:182–194CrossRef Robertson WG, Scurr DS, Bridge CM (1981) Factors influencing crystallization of calcium oxalate in urine—critique. J Cryst Growth 53:182–194CrossRef
13.
Zurück zum Zitat Hess B, Jost C, Zipperle L, Takkinen R, Jaeger Ph (1998) High-calcium intake abolishes hyperoxaluria and reduces urinary crystallization during a 20-fold normal oxalate load in humans. Nephrol Dial Transplant 13:2241–2247CrossRefPubMed Hess B, Jost C, Zipperle L, Takkinen R, Jaeger Ph (1998) High-calcium intake abolishes hyperoxaluria and reduces urinary crystallization during a 20-fold normal oxalate load in humans. Nephrol Dial Transplant 13:2241–2247CrossRefPubMed
14.
Zurück zum Zitat Borghi L, Schianchi T, Meschi T, Guerra A, Allegri F, Maggiore U, Novarini A (2002) Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med 346:77–84CrossRefPubMed Borghi L, Schianchi T, Meschi T, Guerra A, Allegri F, Maggiore U, Novarini A (2002) Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med 346:77–84CrossRefPubMed
15.
Zurück zum Zitat Pak CYC (1991) Citrate and renal calculi: new insights and future directions. Am J Kidney Dis 17:420–425CrossRefPubMed Pak CYC (1991) Citrate and renal calculi: new insights and future directions. Am J Kidney Dis 17:420–425CrossRefPubMed
17.
Zurück zum Zitat Mattle D, Hess B (2005) Preventive treatment of nephrolithiasis with alkali citrate—a critical review. Urol Res 33:73–79CrossRefPubMed Mattle D, Hess B (2005) Preventive treatment of nephrolithiasis with alkali citrate—a critical review. Urol Res 33:73–79CrossRefPubMed
18.
Zurück zum Zitat Kocvara R, Plasgura P, Petrik A, Louzensky G, Bartonickova K, Dvoracek J (1999) A prospective study of nonmedical prophylaxis after a first kidney stone. Brit J Urol Int 84:393–398CrossRef Kocvara R, Plasgura P, Petrik A, Louzensky G, Bartonickova K, Dvoracek J (1999) A prospective study of nonmedical prophylaxis after a first kidney stone. Brit J Urol Int 84:393–398CrossRef
Metadaten
Titel
Renal stone clinic survey: calcium stone formers’ self-declared understanding of and adherence to physician’s recommendations
verfasst von
Bernhard Hess
Publikationsdatum
29.08.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Urolithiasis / Ausgabe 4/2017
Print ISSN: 2194-7228
Elektronische ISSN: 2194-7236
DOI
https://doi.org/10.1007/s00240-016-0916-3

Weitere Artikel der Ausgabe 4/2017

Urolithiasis 4/2017 Zur Ausgabe

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.